Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
MA06 - Resectable and Unresectable Locally Advanced Lung Cancer
- 12:15 - 13:15
- 8/08/2022
- Location: Lehar 1
- Not for CME Credit
- Type: Mini Oral
- Track: Locally Advanced Non-small Cell Lung Cancer
- Moderators:Saulius Cicenas, Celine Mascaux
-
+
Session Moderator
12:16 - 12:17 | Presenter: Saulius Cicenas
- Abstract
Loading... -
+
Session Moderator
12:16 - 12:17 | Presenter: Celine Mascaux
- Abstract
Loading... -
+
MA06.01 - Session Introduction
12:15 - 12:16 | Presenter: Saulius Cicenas
- Abstract
Loading... -
+
MA06.02 - Session Introduction
12:16 - 12:17 | Presenter: Celine Mascaux
- Abstract
Loading... -
+
MA06.03 - Pre-treatment ctDNA Levels Significantly Predicts of OS and PFS in NADIM II Trial
12:17 - 12:22 | Presenter: Atocha Romero
- Abstract
Loading... -
+
MA06.04 - Phase II Study of Durvalumab Plus Concurrent Radiotherapy in Unresectable Locally Advanced NSCLC: DOLPHIN Study (WJOG11619L)
12:22 - 12:27 | Presenter: Motoko Tachihara
- Abstract
Loading... -
+
MA06.05 - Consolidation Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation for Patients with Unresectable Stage III NSCLC
12:27 - 12:32 | Presenter: Greg Andrew Durm
- Abstract
Loading... -
+
MA06.06 - Discussant
12:32 - 12:42 | Presenter: Andrea Bille
- Abstract
Loading... -
+
MA06.07 - Molecular Typing of pN2 Lung Adenocarcinoma: A Retrospective Study Based on Transcriptome Sequencing
12:42 - 12:47 | Presenter: Jianfei Zhu
- Abstract
Loading... -
+
MA06.08 - Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLC
12:47 - 12:52 | Presenter: Wilfried Ernst Erich Eberhardt
- Abstract
Loading... -
+
MA06.09 - Deep Learning for Predicting MPR to Neoadjuvant Immunotherapy in NSCLC
12:52 - 12:57 | Presenter: Yifan Zhong
- Abstract
Loading... -
+
MA06.10 - Discussant
12:57 - 13:07 | Presenter: Dawn Owen
- Abstract
Loading... -
+
MA06.11 - Live Q&A
13:07 - 13:15
- Abstract
Loading...
